Abstract
This study compared the ability of telavancin to the ability of cefazolin and vancomycin to eliminate staphylococci from peritoneal dialysis fluid by using a static in vitro model to simulate the conditions of peritoneal dialysis. The results showed that telavancin exhibited statistically significantly better kill (P < 0.05) against both methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Original language | English (US) |
---|---|
Pages (from-to) | 4521-4524 |
Number of pages | 4 |
Journal | Antimicrobial agents and chemotherapy |
Volume | 51 |
Issue number | 12 |
DOIs | |
State | Published - Dec 2007 |